About AOU Maggiore della Carità di Novara - SCDU Ematologia
Clinical Trials at AOU Maggiore della Carità di Novara - SCDU Ematologia
During the past decade, AOU Maggiore della Carità di Novara - SCDU Ematologia conducted 22 clinical trials. In the 10-year time frame, 22 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "AOU Maggiore della Carità di Novara - SCDU Ematologia"
#1 collaborator was "AbbVie" with 1 trials as a collaborator, "Centro di Riferimento per l'Epidemiologia e la Prev. Oncologica Piemonte" with 1 trials as a collaborator, "Hematology Project Foundation" with 1 trials as a collaborator, "Istituto Clinico Humanitas" with 1 trials as a collaborator and "Janssen-Cilag S.p.A." with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were
collaborators in the rest 5 trials.
Clinical Trials Conditions at AOU Maggiore della Carità di Novara - SCDU Ematologia
According to Clinical.Site data, the most researched conditions in "AOU Maggiore della Carità di Novara - SCDU Ematologia" are
"Follicular Lymphoma" (4 trials), "Chronic Lymphocytic Leukemia" (2 trials), "Hodgkin's Lymphoma" (2 trials), "Mantle Cell Lymphoma" (2 trials) and "Non-Hodgkin's Lymphoma" (2 trials). Many other conditions were trialed in "AOU Maggiore della Carità di Novara - SCDU Ematologia" in a lesser frequency.
Clinical Trials Intervention Types at AOU Maggiore della Carità di Novara - SCDU Ematologia
Most popular intervention types in "AOU Maggiore della Carità di Novara - SCDU Ematologia" are "Drug" (20 trials) and "Other" (6 trials). Other intervention types were less common.
The name of intervention was led by "Venetoclax" (6 trials), "Rituximab" (4 trials), "Obinutuzumab" (3 trials), "Bendamustine" (2 trials) and "Fostamatinib disodium" (2 trials). Other intervention names were less common.
Clinical Trials Genders at AOU Maggiore della Carità di Novara - SCDU Ematologia
The vast majority of trials in "AOU Maggiore della Carità di Novara - SCDU Ematologia" are
28 trials for "All" genders.
Clinical Trials Status at AOU Maggiore della Carità di Novara - SCDU Ematologia
Currently, there are 15 active trials in "AOU Maggiore della Carità di Novara - SCDU Ematologia".
1 are not yet recruiting,
6 are recruiting,
7 are Active, not recruiting,
and 1 are Enrolling by invitation.
In total, there were 10 completed trials in AOU Maggiore della Carità di Novara - SCDU Ematologia,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in AOU Maggiore della Carità di Novara - SCDU Ematologia, 2 "Phase 1"
clinical trials were conducted, 12 "Phase 2" clinical
trials and 4 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".